{"pmid":32352650,"title":"Zooming Towards a Telehealth Solution for Vulnerable Children with Obesity During COVID-19.","text":["Zooming Towards a Telehealth Solution for Vulnerable Children with Obesity During COVID-19.","Health inequities exist throughout the life course, resulting in racial/ethnic and socioeconomic disparities in obesity and obesity-related health complications. Obesity and its co-morbidities appear linked to COVID-19 mortality. Approaches to reduce obesity in the time of COVID-19 closures are urgently needed and should start early in life. In New York City, we developed a telehealth pediatric weight management collaborative spanning NewYork-Presbyterian, Columbia University Vagelos College of Physicians and Surgeons, and Weill Cornell Medicine during COVID-19 with show rates 76-89%. To stave off the impending exacerbation of health disparities related to obesity risk factors in the aftermath of the COVID-19 pandemic, effective interventions that can be delivered remotely are urgently needed among vulnerable children with obesity. Challenges in digital technology access, social and linguistic differences, privacy security, and reimbursement must be overcome to realize the full potential of telehealth for pediatric weight management among low-income and racial/ethnic minority children.","Obesity (Silver Spring)","Woo Baidal, Jennifer A","Chang, Jane","Hulse, Emma","Turetsky, Robyn","Parkinson, Kristina","Rausch, John C","32352650"],"abstract":["Health inequities exist throughout the life course, resulting in racial/ethnic and socioeconomic disparities in obesity and obesity-related health complications. Obesity and its co-morbidities appear linked to COVID-19 mortality. Approaches to reduce obesity in the time of COVID-19 closures are urgently needed and should start early in life. In New York City, we developed a telehealth pediatric weight management collaborative spanning NewYork-Presbyterian, Columbia University Vagelos College of Physicians and Surgeons, and Weill Cornell Medicine during COVID-19 with show rates 76-89%. To stave off the impending exacerbation of health disparities related to obesity risk factors in the aftermath of the COVID-19 pandemic, effective interventions that can be delivered remotely are urgently needed among vulnerable children with obesity. Challenges in digital technology access, social and linguistic differences, privacy security, and reimbursement must be overcome to realize the full potential of telehealth for pediatric weight management among low-income and racial/ethnic minority children."],"journal":"Obesity (Silver Spring)","authors":["Woo Baidal, Jennifer A","Chang, Jane","Hulse, Emma","Turetsky, Robyn","Parkinson, Kristina","Rausch, John C"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32352650","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1002/oby.22860","keywords":["community health","health systems","pediatrics","weight management"],"locations":["New York"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1666138495740018688,"score":9.490897,"similar":[{"pmid":32365269,"title":"Obesity and severe COVID-19 disease: a strong association.","text":["Obesity and severe COVID-19 disease: a strong association.","After having read your recent Editorial \"COVID 19 and the Patient with Obesity - The Editors Speak Out\"(1) , I wish to share my own personal experience. I am an anesthesiologist working on the frontline of the coronavirus (SARS-CoV-2) pandemic at an academic and teaching establishment, Weill Cornell Medical College, New York-Presbyterian Hospital, in New York City. As Director of the Bariatric Anesthesia division, and an airway expert, I was assigned to our COVID Airway Team, in March 2020.","Obesity (Silver Spring)","Samuels, Jon D","32365269"],"abstract":["After having read your recent Editorial \"COVID 19 and the Patient with Obesity - The Editors Speak Out\"(1) , I wish to share my own personal experience. I am an anesthesiologist working on the frontline of the coronavirus (SARS-CoV-2) pandemic at an academic and teaching establishment, Weill Cornell Medical College, New York-Presbyterian Hospital, in New York City. As Director of the Bariatric Anesthesia division, and an airway expert, I was assigned to our COVID Airway Team, in March 2020."],"journal":"Obesity (Silver Spring)","authors":["Samuels, Jon D"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32365269","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1002/oby.22866","locations":["New York"],"countries":["United States"],"countries_codes":["USA|United States"],"weight":0,"_version_":1666138495974899712,"score":346.56818},{"pmid":32339394,"title":"Measuring weight with e-scales in clinical and research settings during the COVID-19 pandemic.","text":["Measuring weight with e-scales in clinical and research settings during the COVID-19 pandemic.","With the COVID-19 pandemic, clinicians and researchers have been suddenly confronted with the difficulty of treatment provision and continuation of clinical trials without face-to-face contact. This predicament has resulted in the rapid adoption of telehealth methodologies.(1) Clinicians and researchers focused on obesity management have an additional need-- a remote way to measure weight. In this piece, we will describe electronic scales (e-scales) and provide guidance on how clinicians/researchers might best implement e-scales in their clinical practice or research studies to remotely measure weight.","Obesity (Silver Spring)","Krukowski, Rebecca A","Ross, Kathryn M","32339394"],"abstract":["With the COVID-19 pandemic, clinicians and researchers have been suddenly confronted with the difficulty of treatment provision and continuation of clinical trials without face-to-face contact. This predicament has resulted in the rapid adoption of telehealth methodologies.(1) Clinicians and researchers focused on obesity management have an additional need-- a remote way to measure weight. In this piece, we will describe electronic scales (e-scales) and provide guidance on how clinicians/researchers might best implement e-scales in their clinical practice or research studies to remotely measure weight."],"journal":"Obesity (Silver Spring)","authors":["Krukowski, Rebecca A","Ross, Kathryn M"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32339394","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1002/oby.22851","keywords":["biomedical technology","body weight","clinical care","clinical trials","community health"],"weight":0,"_version_":1666138494270963712,"score":271.99896},{"pmid":32249357,"pmcid":"PMC7130453","title":"Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic.","text":["Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic.","AIMS: Analyze the relationship between obesity and influenza. METHODS: Basal hormone milieu, defective response of both innate and adaptive immune system and sedentariness are major determinants in the severity of influenza viral infection in obese patients. Being overweight not only increases the risk of infection and of complications for the single obese person, but a large prevalence of obese individuals within the population might increase the chance of appearance of more virulent viral strain, prolongs the virus shedding throughout the total population and eventually might increase overall mortality rate of an influenza pandemic. RESULTS: Waiting for the development of a vaccination against COVID-19, isolation of positive cases and social distancing are the primary interventions. Nonetheless, evidence from previous influenza pandemics suggests the following interventions aimed at improving immune response: (1) lose weight with a mild caloric restriction; (2) include AMPK activators and PPAR gamma activators in the drug treatment for obesity associated with diabetes; and (3) practice mild-to-moderate physical exercise. CONCLUSIONS: Due to prolonged viral shedding, quarantine in obese subjects should likely be longer than normal weight individuals.","Acta Diabetol","Luzi, Livio","Radaelli, Maria Grazia","32249357"],"abstract":["AIMS: Analyze the relationship between obesity and influenza. METHODS: Basal hormone milieu, defective response of both innate and adaptive immune system and sedentariness are major determinants in the severity of influenza viral infection in obese patients. Being overweight not only increases the risk of infection and of complications for the single obese person, but a large prevalence of obese individuals within the population might increase the chance of appearance of more virulent viral strain, prolongs the virus shedding throughout the total population and eventually might increase overall mortality rate of an influenza pandemic. RESULTS: Waiting for the development of a vaccination against COVID-19, isolation of positive cases and social distancing are the primary interventions. Nonetheless, evidence from previous influenza pandemics suggests the following interventions aimed at improving immune response: (1) lose weight with a mild caloric restriction; (2) include AMPK activators and PPAR gamma activators in the drug treatment for obesity associated with diabetes; and (3) practice mild-to-moderate physical exercise. CONCLUSIONS: Due to prolonged viral shedding, quarantine in obese subjects should likely be longer than normal weight individuals."],"journal":"Acta Diabetol","authors":["Luzi, Livio","Radaelli, Maria Grazia"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32249357","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1007/s00592-020-01522-8","keywords":["covid-19","immune-modulation","influenza","obese subjects"],"locations":["obese","obese","obese","obese"],"topics":["Treatment"],"weight":1,"_version_":1666138491031912449,"score":252.69124},{"pmid":32409502,"title":"Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.","text":["Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.","OBJECTIVE: Patients with obesity are at increased risk of exacerbations from viral respiratory infections. However, the association of obesity with the severity of coronavirus disease 2019 (COVID-19) is unclear. We examined this association using data from the only referral hospital in Shenzhen, China. RESEARCH DESIGN AND METHODS: A total of 383 consecutively hospitalized patients with COVID-19 admitted from 11 January 2020 to 16 February 2020 and followed until 26 March 2020 at the Third People's Hospital of Shenzhen were included. Underweight was defined as a BMI <18.5 kg/m(2), normal weight as 18.5-23.9 kg/m(2), overweight as 24.0-27.9 kg/m(2), and obesity as >/=28 kg/m(2). RESULTS: Of the 383 patients, 53.1% were normal weight, 4.2% were underweight, 32.0% were overweight, and 10.7% were obese at admission. Obese patients tended to have symptoms of cough (P = 0.03) and fever (P = 0.06) compared with patients who were not obese. Compared with normal weight patients, those who were overweight had 1.84-fold odds of developing severe COVID-19 (odds ratio [OR] 1.84, 95% CI 0.99-3.43, P = 0.05), while those who were obese were at 3.40-fold odds of developing severe disease (OR 3.40, 95% CI 1.40-2.86, P = 0.007), after adjusting for age, sex, epidemiological characteristics, days from disease onset to hospitalization, presence of hypertension, diabetes, cardiovascular disease, chronic obstructive pulmonary disease, liver disease and cancer, and drug used for treatment. Additionally, after similar adjustment, men who were obese versus those who were normal weight were at increased odds of developing severe COVID-19 (OR 5.66, 95% CI 1.80-17.75, P = 0.003). CONCLUSIONS: In this study, obese patients had increased odds of progressing to severe COVID-19. As the severe acute respiratory syndrome coronavirus 2 may continue to spread worldwide, clinicians should pay close attention to obese patients, who should be carefully managed with prompt and aggressive treatment.","Diabetes Care","Cai, Qingxian","Chen, Fengjuan","Wang, Tao","Luo, Fang","Liu, Xiaohui","Wu, Qikai","He, Qing","Wang, Zhaoqin","Liu, Yingxia","Liu, Lei","Chen, Jun","Xu, Lin","32409502"],"abstract":["OBJECTIVE: Patients with obesity are at increased risk of exacerbations from viral respiratory infections. However, the association of obesity with the severity of coronavirus disease 2019 (COVID-19) is unclear. We examined this association using data from the only referral hospital in Shenzhen, China. RESEARCH DESIGN AND METHODS: A total of 383 consecutively hospitalized patients with COVID-19 admitted from 11 January 2020 to 16 February 2020 and followed until 26 March 2020 at the Third People's Hospital of Shenzhen were included. Underweight was defined as a BMI <18.5 kg/m(2), normal weight as 18.5-23.9 kg/m(2), overweight as 24.0-27.9 kg/m(2), and obesity as >/=28 kg/m(2). RESULTS: Of the 383 patients, 53.1% were normal weight, 4.2% were underweight, 32.0% were overweight, and 10.7% were obese at admission. Obese patients tended to have symptoms of cough (P = 0.03) and fever (P = 0.06) compared with patients who were not obese. Compared with normal weight patients, those who were overweight had 1.84-fold odds of developing severe COVID-19 (odds ratio [OR] 1.84, 95% CI 0.99-3.43, P = 0.05), while those who were obese were at 3.40-fold odds of developing severe disease (OR 3.40, 95% CI 1.40-2.86, P = 0.007), after adjusting for age, sex, epidemiological characteristics, days from disease onset to hospitalization, presence of hypertension, diabetes, cardiovascular disease, chronic obstructive pulmonary disease, liver disease and cancer, and drug used for treatment. Additionally, after similar adjustment, men who were obese versus those who were normal weight were at increased odds of developing severe COVID-19 (OR 5.66, 95% CI 1.80-17.75, P = 0.003). CONCLUSIONS: In this study, obese patients had increased odds of progressing to severe COVID-19. As the severe acute respiratory syndrome coronavirus 2 may continue to spread worldwide, clinicians should pay close attention to obese patients, who should be carefully managed with prompt and aggressive treatment."],"journal":"Diabetes Care","authors":["Cai, Qingxian","Chen, Fengjuan","Wang, Tao","Luo, Fang","Liu, Xiaohui","Wu, Qikai","He, Qing","Wang, Zhaoqin","Liu, Yingxia","Liu, Lei","Chen, Jun","Xu, Lin"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32409502","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.2337/dc20-0576","locations":["Shenzhen","China","Obese","obese","obese","obese","obese","obese","Shenzhen","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666897319116668929,"score":239.77701},{"pmid":32454174,"title":"Projecting the impact of COVID-19 pandemic on childhood obesity in the U.S.: A microsimulation model.","text":["Projecting the impact of COVID-19 pandemic on childhood obesity in the U.S.: A microsimulation model.","OBJECTIVE: The COVID-19 pandemic in the U.S. led to nationwide stay-at-home orders and school closures. Declines in energy expenditure resulting from canceled physical education classes and reduced physical activity (PA) may elevate childhood obesity risk. This study estimated the impact of COVID-19 on childhood obesity. METHODS: A microsimulation model simulated the trajectory of a nationally representative kindergarten cohort's body mass index z-scores (BMIz) and childhood obesity prevalence from April 2020 to March 2021 under the control scenario without COVID-19 and under the 4 alternative scenarios with COVID-19-Scenario 1: 2-month nationwide school closure in April and May 2020; Scenario 2: Scenario 1 followed by a 10% reduction in daily PA in summer from June to August; Scenario 3: Scenario 2 followed by 2-month school closure in September and October; and Scenario 4: Scenario 3 followed by an additional 2-month school closure in November and December. RESULTS: Relative to the control scenario without COVID-19, Scenarios 1, 2, 3, and 4 were associated with an increase in the mean BMIz by 0.056 (95% confidence interval (95%CI): 0.055-0.056), 0.084 (95%CI: 0.084-0.085), 0.141 (95%CI: 0.140-0.142), and 0.198 (95%CI: 0.197-0.199), respectively, and an increase in childhood obesity prevalence by 0.640 (95%CI: 0.515-0.765), 0.972 (95%CI: 0.819-1.126), 1.676 (95%CI: 1.475-1.877), and 2.373 (95%CI: 2.135-2.612) percentage points, respectively. Compared to girls and non-Hispanic whites and Asians, the impact of COVID-19 on childhood obesity was modestly larger among boys and non-Hispanic blacks and Hispanics, respectively. CONCLUSION: Public health interventions are urgently called to promote an active lifestyle and engagement in PA among children to mitigate the adverse impact of COVID-19 on unhealthy weight gains and childhood obesity.","J Sport Health Sci","An, Ruopeng","32454174"],"abstract":["OBJECTIVE: The COVID-19 pandemic in the U.S. led to nationwide stay-at-home orders and school closures. Declines in energy expenditure resulting from canceled physical education classes and reduced physical activity (PA) may elevate childhood obesity risk. This study estimated the impact of COVID-19 on childhood obesity. METHODS: A microsimulation model simulated the trajectory of a nationally representative kindergarten cohort's body mass index z-scores (BMIz) and childhood obesity prevalence from April 2020 to March 2021 under the control scenario without COVID-19 and under the 4 alternative scenarios with COVID-19-Scenario 1: 2-month nationwide school closure in April and May 2020; Scenario 2: Scenario 1 followed by a 10% reduction in daily PA in summer from June to August; Scenario 3: Scenario 2 followed by 2-month school closure in September and October; and Scenario 4: Scenario 3 followed by an additional 2-month school closure in November and December. RESULTS: Relative to the control scenario without COVID-19, Scenarios 1, 2, 3, and 4 were associated with an increase in the mean BMIz by 0.056 (95% confidence interval (95%CI): 0.055-0.056), 0.084 (95%CI: 0.084-0.085), 0.141 (95%CI: 0.140-0.142), and 0.198 (95%CI: 0.197-0.199), respectively, and an increase in childhood obesity prevalence by 0.640 (95%CI: 0.515-0.765), 0.972 (95%CI: 0.819-1.126), 1.676 (95%CI: 1.475-1.877), and 2.373 (95%CI: 2.135-2.612) percentage points, respectively. Compared to girls and non-Hispanic whites and Asians, the impact of COVID-19 on childhood obesity was modestly larger among boys and non-Hispanic blacks and Hispanics, respectively. CONCLUSION: Public health interventions are urgently called to promote an active lifestyle and engagement in PA among children to mitigate the adverse impact of COVID-19 on unhealthy weight gains and childhood obesity."],"journal":"J Sport Health Sci","authors":["An, Ruopeng"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32454174","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.jshs.2020.05.006","keywords":["covid-19","childhood obesity","coronavirus","microsimulation","physical activity"],"locations":["USA","non-Hispanic","Asians","non-Hispanic","Hispanics","USA"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention","Epidemic Forecasting"],"weight":1,"_version_":1667881798550421504,"score":239.72585}]}